3.62000 EUR
0.04
1.09%
Last update Dec 15, 3:29 PM CET
Main market
Day range
3.62000
3.66000
Previous close
3.66000
Open
3.66000
Access this stock data via API
Subscribe
Nervgen Pharma Corp.
3.62
0.04
1.09%

Financials

Income statement

Fundamentals currency is CAD
Fiscal date 2024 2023 2022 2021
Total reported revenue 0 0 0 0
Cost of revenue
Gross profit
Operating expense
Research & development 9.7M 8.0M 16.6M 6.9M
Selling general and admin 5.7M 9.6M 6.3M 5.9M
Other operating expenses
Operating income -15.4M -17.8M -23.0M -12.8M
Non operating interest income
Income 503.1K 550.1K 201.4K 29.4K
Expense 0 514.6K 0
Other income expense 70.3K -5.2M 2.6M 55.2K
Pretax income -14.9M -22.4M -20.7M -12.7M
Tax provision
Net income -14.9M -22.4M -20.7M -12.7M
Basic EPS -0.4 -0.4 -0.4 -0.3
Diluted EPS -0.4 -0.4 -0.4 -0.3
Basic average shares 41.7M 92.0M 78.0M 58.2M
Diluted average shares 41.7M 92.0M 78.0M 58.2M
EBITDA -15.5M -17.1M -22.7M -12.7M
Net income from continuing op. -14.9M -22.4M -20.7M -12.7M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 7 hours 40 minutes

14:19
00:00
08:00
22:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 22:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).